Clinical trial
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot…
NCT00309946 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00309946 |
|---|---|
| Title | Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery |
| Official title | Phase II Study of AZD2171 (NSC#732208) in Patients With Malignant Mesothelioma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Localized Malignant Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma |
| Intervention type | Drug |
| Interventions | cediranib maleate |
| Enrollment | 51 |
| Start date | Dec 1, 2005 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Apr 3, 2006 |
| Last update posted | Jul 31, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: